Singapore, May 13 -- Sanyou Biopharmaceuticals Co. and TransRecoBio Biotechnology Co. have signed a strategic cooperation agreement. The two companies will integrate their core strengths in antibody drug discovery and innovative formulation manufacturing, with a focus on addressing major unmet clinical needs in ophthalmology, autoimmune diseases, metabolic disorders, anti-aging, and infectious diseases.

Together, they will advance the development of cutting-edge formulations such as eye drops, topical gels, and inhalation agents, creating an end-to-end solution covering R&D, manufacturing, and commercialisation, thereby accelerating the development of novel drug formulations.

This strategic partnership pioneers a new collaborative model...